Long-Term Assets: The sum of all assets classified as non-current.
Sagimet Biosciences Inc. (SGMT) had Long-Term Assets of $8.92M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-12.91M |
|
-- |
|
-- |
|
$14.33M |
|
$-14.33M |
|
$1.43M |
|
$-12.91M |
|
$-12.91M |
|
$-12.91M |
|
$-12.91M |
|
$-12.91M |
|
$-12.91M |
|
$-14.33M |
|
$-14.26M |
|
32.47M |
|
32.47M |
|
$-0.40 |
|
$-0.40 |
|
| Balance Sheet Financials | |
$119.48M |
|
-- |
|
|
Long-Term Assets |
$8.92M |
$128.40M |
|
$9.15M |
|
-- |
|
-- |
|
$9.15M |
|
$119.25M |
|
$119.25M |
|
$119.25M |
|
32.52M |
|
| Cash Flow Statement Financials | |
$-33.82M |
|
$-9.80M |
|
$0.28M |
|
$75.84M |
|
$32.50M |
|
$-43.34M |
|
$4.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-33.82M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.82% |
|
-10.82% |
|
-10.05% |
|
-10.82% |
|
$3.67 |
|
$-1.04 |
|
$-1.04 |
|